Mag 7 Evaporates Two Trillion|Rewire Morning News Brief

marsbit發佈於 2026-03-30更新於 2026-03-30

文章摘要

Two major conflicts are converging as Ukraine's drone attacks disable 40% of Russia's oil export capacity, while Russia equips Iran with advanced AI drones featuring Starlink communications. This signals merging global risk networks. Concurrently, the Magnificent 7 tech stocks have lost over $2 trillion in value, with markets now pricing in a potential interest rate hike this year as inflation concerns persist. A sector rotation from growth stocks to energy and defense is underway. In AI developments, Anthropic is privately warning US officials that its unreleased "Mythos" model could make large-scale cyber attacks significantly more likely by 2026, representing a leap in AI-powered offensive capabilities. Additionally, Eli Lilly makes a landmark $2.75 billion bet on AI drug discovery through a partnership with Insilico Medicine, aiming to compress drug development timelines from years to months. Other notable developments include US stablecoin regulation advancing, Musk warning that AI's growth is limited by power supply constraints, and AI policy becoming an independent issue in US midterm elections.

The battle lines of Iran and Ukraine are intersecting. In the same week that Russia equipped Iranian drones with Starlink, Ukraine destroyed 40% of Russia's oil export capacity. Capital markets have finally grasped it: these are not two isolated conflicts, but a merging global risk network.

1| Two Wars Converge: Ukraine Bombs Russian Oil Ports, Russia Gives Iran Starlink

Ukraine launched consecutive drone strikes on three major Russian oil export ports this week. Primorsk on March 23rd, Ust-Luga on the 25th, and the Kirishi refinery on the 26th. Reuters calculates that about 2 million barrels per day of export capacity were taken offline, accounting for 40% of Russia's total export capacity, "the most severe oil supply disruption in modern Russian history."

In the same week, Fortune reported that Russia is providing Iran with upgraded Shahed drones, featuring new AI computing platforms, jet engines, Starlink communication capabilities, and anti-jamming equipment. Western intelligence also shows Russia is providing Iran with real-time satellite positioning of US military assets. On the other side, Ukraine signed a security agreement with Saudi Arabia to share counter-drone technology, and Zelenskyy made secret visits to the UAE and Qatar.

University of Pittsburgh political science professor Spaniel says "we are not at a real world war yet," but the warring parties, weapons supply chains, and intelligence networks of the two conflicts are already intersecting. Washington is still considering diverting part of its military aid to the Middle East. (Continuation of yesterday's report)

(Sources: Fortune / Reuters / Moscow Times / FPRI / Time)

2| Mag 7 Evaporates Over $2 Trillion, Market Prices In Rate Hike for the First Time This Year

The Magnificent 7 have collectively lost over $2 trillion in market value from their historical highs. Microsoft is down 32% from its October high, its worst start to a year in company history. Meta is down 25%, Alphabet down 15%, and Nvidia and Amazon have turned negative for the year. The S&P 500 fell for five consecutive weeks, its longest losing streak since 2022.

A key expectation flip occurred in the futures market. Traders pushed the probability of a rate hike within the year to 52%, breaking the 50% threshold for the first time. The Atlanta Fed tracker shows a 19.8% probability of a 25 basis point hike. The Fed held rates steady in its March meeting, but Powell "expressed concern" about the lack of progress on inflation. Global forecasting agencies have raised their CPI expectations to 4.2%, far exceeding the Fed's forecast of 2.7%. EY-Parthenon raised the probability of a US recession to 40%.

Institutional funds are shifting from tech growth stocks to energy, defense, and domestic manufacturing. The Mag 7 gained 107%, 67%, and 25% over the past three years; now all seven stocks are in the red for the year. The problem isn't just oil prices; it's that $650 billion in AI capital expenditure has become a burden in a rising rate cycle.

(Sources: Fortune / CNBC / Yahoo Finance / EY-Parthenon / Atlanta Fed)

3| Anthropic Warns Government: Mythos Model Makes Large-Scale Cyber Attacks "More Likely"

Anthropic is privately warning senior US officials that its unreleased "Mythos" model makes a large-scale cyber attack in 2026 "more likely to occur." Previously, information about the model was accidentally leaked due to a CMS system failure, after which the company confirmed Mythos is its "most powerful model to date," representing a "step-change in capabilities."

Axios reported that the model "far surpasses any other AI model in cyber capabilities," allowing agents to "autonomously penetrate corporate, government, and municipal systems with stunning precision." A Dark Reading survey showed 48% of cybersecurity professionals list agent AI as the top attack vector for 2026, surpassing deepfakes and all other threats. Cybersecurity stocks fell on the news, and Evercore issued commentary.

QuantumBit concurrently reported that Claude discovered a 20-year-old system vulnerability in 90 minutes. These two events point to the same inflection point: the growth rate of AI's offensive capabilities is now faster than its defensive capabilities. Frontier labs are no longer just selling products; they are redefining who can breach whom.

(Sources: Axios / Fortune / CNBC / Evercore / QuantumBit)

4| Lilly Bets $2.75 Billion on AI Drug Discovery, Rewriting Traditional R&D Timelines

Eli Lilly signed a $2.75 billion AI drug discovery agreement with Hong Kong's Insilico Medicine, paying $115 million upfront for global exclusive development and commercialization rights. Insilico has used generative AI to develop 28 drugs, nearly half of which are in clinical stages. The two companies have collaborated since 2023, aiming to compress the cycle from target discovery to new drug application from the traditional several years to a few months.

This is the largest single agreement for AI drug discovery by a major pharmaceutical company. Previous AI pharma deals were mostly research collaborations and milestone payments; Lilly directly buying commercialization rights effectively prices AI drug pipelines using traditional pharma valuation logic. STAT News points out that Insilico's core competency lies in using AI for both target discovery and molecular design simultaneously, parallelizing the two most time-consuming steps. When AI is not just an辅助工具 but the pipeline itself, the valuation logic of the pharmaceutical industry may be rewritten.

(Sources: CNBC / Bloomberg / STAT News)

Also Worth Knowing ↓

CLARITY Act stablecoin yield compromise reached, DeFi tokens face headwinds. Senators Tillis and Alsobrooks reached a principled agreement: passive holding yields are banned, active rewards are retained. Protocols like Uniswap, Aave, dYdX may be restricted. Bank committee review scheduled for late April. Stablecoins are being legislatively redefined from speculative tools to payment instruments, forcing a structural adjustment to DeFi's yield models. (Source: CoinDesk / Congress.gov)

Musk warns US chip capacity will soon exceed power supply, a problem China doesn't have. Speaking at Davos with BlackRock CEO Fink, he said the fundamental limiting factor for AI deployment is electricity, as chip capacity grows exponentially but power cannot keep up. The bottleneck in the AI arms race is shifting from supply chains to the power grid. (Source: Fortune)

Southeast Asian stablecoin payments go "invisible," crypto card business surges. Users no longer directly interact with crypto assets as stablecoins are embedded into daily consumption payments. This aligns with the CLARITY Act's direction of positioning stablecoins as payment tools, a signal that crypto is moving from speculation to infrastructure, evident in both legislation and product development. (Source: CoinDesk)

Cambridge University's new memristor chip reduces AI switching current by a million times. New materials solve the energy consumption and precision bottlenecks of traditional memristors, potentially fundamentally changing the energy efficiency of AI inference. Still in the lab stage, but the direction echoes Musk's point that "electricity is the limiting factor." (Source: Tom's Hardware)

Trump's AI agenda becomes an independent campaign issue for the first time in midterm elections. A new political group formed specifically to push AI policy into the 2026 midterm elections. AI governance is moving from the executive order stage into electoral politics. (Source: New York Times)

相關問答

QWhat is the significance of Ukraine's drone attacks on Russian oil ports and Russia's provision of Starlink to Iran, according to the article?

AThe article indicates that these events show the convergence of two previously isolated conflicts into a single, interconnected global risk network, involving cross-over of participants, weapons supply chains, and intelligence networks.

QHow much market value have the Magnificent 7 tech stocks lost, and what key shift in market expectations is driving this change?

AThe Magnificent 7 have lost over $2 trillion in market value from their peaks. A key driver is a shift in market expectations, with traders now pricing in a greater than 50% probability of an interest rate *hike* within the year, contrary to previous expectations of cuts.

QWhat specific warning did Anthropic give to US officials regarding its 'Mythos' model, and what capability does it demonstrate?

AAnthropic warned US officials that its unreleased 'Mythos' model makes a large-scale cyber attack by 2026 'more likely.' The model is described as a 'step-change in capability' that allows AI agents to autonomously penetrate corporate, government, and municipal systems with stunning precision.

QWhat is the size and significance of Eli Lilly's $2.75 billion deal with Insilico Medicine?

AEli Lilly's deal with Insilico Medicine is worth up to $2.75 billion with a $115 million upfront payment. It is the largest single deal for an AI-pharma partnership and signifies a shift as a major pharma company is using traditional drug valuation logic to price an AI-generated drug pipeline, potentially rewriting industry R&D timelines.

QAccording to Elon Musk at Davos, what is the fundamental limiting factor for AI deployment, and how does China compare?

AElon Musk stated that the fundamental limiting factor for AI deployment is electrical power supply, not just chips. He warned that US chip capacity is growing exponentially while power supply is not, and noted that China does not have this particular problem.

你可能也喜歡

加密IPO寒冬:Consensys与Ledger集体撤单

2026年加密行业IPO热潮明显降温。5月中旬,头部企业MetaMask开发商Consensys将其IPO计划推迟至最早今年秋季,而硬件钱包巨头Ledger也已暂停其美国上市计划。此前,交易所Kraken的上市进程同样放缓。这与2025年加密公司上市火热、融资额巨大的景象形成鲜明对比。 导致这一转变的原因是多方面的。首先,市场环境恶化:比特币价格在2026年大幅回调,交易量下滑,投资者风险偏好降低。2025年上市的加密股(如Circle、Bullish)及2026年初上市的BitGo,股价均经历显著下跌,加剧了市场对新上市加密资产的谨慎态度。其次,板块资金分流:当前资本市场高度聚焦人工智能(AI)领域,SpaceX、OpenAI等万亿美元级估值的AI公司正吸引大量长期资本,相比之下,加密公司收入与比特币价格强绑定,波动性大,叙事吸引力减弱。 面对挑战,加密企业战略更趋务实。部分公司转向私募融资或专注于优化产品、拓展机构服务等,以夯实基本面和现金流,等待更好的市场窗口。行业可能因此加速优胜劣汰,资源向合规扎实、基础设施强的企业集中,推动行业从故事驱动向业绩驱动转型。分析认为,若比特币价格能稳定回升至较高区间,且监管环境进一步明确,2026年下半年可能迎来新的IPO机会。

marsbit2 小時前

加密IPO寒冬:Consensys与Ledger集体撤单

marsbit2 小時前

ChatGPT 能替你管钱了,你敢把银行账户交给它吗?

OpenAI于5月15日面向美国ChatGPT Pro用户推出个人理财工具预览功能。用户可通过金融数据服务商Plaid连接银行、投资等账户,授权后ChatGPT可读取余额、交易记录、投资组合等数据,并生成可视化财务仪表盘。用户能以自然语言对话形式进行消费分析、制定购房计划等个性化财务咨询,实现“对话式理财”。 此举是OpenAI战略布局的一部分,此前其已收购个人理财应用Roi和Hiro Finance,并推出健康管理功能,旨在将ChatGPT打造为覆盖高价值决策场景的“超级助手”。然而,功能发布后引发广泛隐私担忧。近期OpenAI正因涉嫌未经同意共享用户聊天数据给Meta和Google而被集体诉讼,此时推出需连接敏感财务数据的产品,加剧了用户对数据安全的顾虑。OpenAI强调该功能仅具数据读取权限,且断开连接后数据将在30天内删除,但用户数据仍可能用于模型训练的选项引发了进一步讨论。 当前AI行业正从通用聊天机器人转向垂直领域深耕。除OpenAI外,Anthropic、Perplexity等公司也纷纷推出面向金融B端或C端的专业工具,争夺高价值数据入口。尽管产品层面设计了安全措施,但AI理财工具在法律上不承担财务顾问责任,其“幻觉”风险与隐私信任问题,是用户是否愿意接纳的关键。这标志着AI正深入个人核心决策领域,也将信任与安全议题推至前台。

marsbit2 小時前

ChatGPT 能替你管钱了,你敢把银行账户交给它吗?

marsbit2 小時前

交易

現貨
合約
活动图片